Evidence map›Paper›PMID 34606335›Full record

ArticleAntimicrobial agents and chemotherapy2021

Isolation of Group A Streptococci with Reduced

Tsubasa Ikeda, Rihito Suzuki, Wanchun Jin, Jun-Ichi Wachino, Yoshichika Arakawa, Kouji Kimura

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Clinical microbiology reviews · 2024
    Review
  3. A review of penicillin binding protein and group AFrontiers in cellular and infection microbiology · 2023
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tsubasa Ikeda *Department of Bacteriology, Nagoya Universitygrid.27476.30 Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0003-0449-3298
Rihito Suzuki *Department of Bacteriology, Nagoya Universitygrid.27476.30 Graduate School of Medicine, Nagoya, Japan.
Wanchun JinDepartment of Bacteriology, Nagoya Universitygrid.27476.30 Graduate School of Medicine, Nagoya, Japan.
Jun-Ichi WachinoDepartment of Bacteriology, Nagoya Universitygrid.27476.30 Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-2619-8380
Yoshichika ArakawaDepartment of Bacteriology, Nagoya Universitygrid.27476.30 Graduate School of Medicine, Nagoya, Japan.
Kouji KimuraDepartment of Bacteriology, Nagoya Universitygrid.27476.30 Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-3783-6333
Nagoya University · JP

Funding

Japan Agency for Medical Research and Development (AMED) the Research Program on Emerging and Re-emerging Infectious Diseases
6 · The paper itself

Abstract

Streptococcus pyogenes (group A Streptococcus [GAS]) has long been regarded as being susceptible to β-lactams. However, amino acid substitutions in penicillin-binding protein 2X (PBP2X) conferring reduced

Indexed as

beta-LactamsStreptococcus pyogenesAmino Acid SubstitutionAnti-Bacterial AgentsBacterial ProteinsJapanMicrobial Sensitivity TestsPenicillin-Binding ProteinsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsPenicillin-Binding Proteinsantibiotic resistancegroup A Streptococcuspenicillin-binding proteinStreptococcus pyogenesβ-lactam

Identifiers

PMID34606335
PMCPMC8597773
OpenAlexW3203008903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.